“…However, in the last 15 years, due in large part to the elegant work of Eilbracht,4 hydroaminomethylation has been intensively investigated1 and utilized for the preparation of diverse pharmaceutical ingredients,5 including cinacalcet (Sensipar, Mimpara),5, 6a ibutilide (Corvert),5, 6b and fexofenadine (Allegra, Fexidine, Telfast, Fastofen, Tilfur, Vifas, Telfexo, Allerfexo) 5. 6c Recent advances in hydroaminomethylation include the use of ammonia as a reactant,4c, 7 regioselective reactions of terminal8a and internal [8b alkenes through ligand control8 or the use of directing groups,9 the evolution from rhodium‐based to ruthenium‐based catalysts,10 and the emergence of noncarbonylative strategies, including hydroaminoalkylation11 [Scheme , Eq. (2)] and photoredox catalysis [Scheme , Eq.…”